1. Home
  2. ACTU vs RMMZ Comparison

ACTU vs RMMZ Comparison

Compare ACTU & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • RMMZ
  • Stock Information
  • Founded
  • ACTU 2015
  • RMMZ 2022
  • Country
  • ACTU United States
  • RMMZ United States
  • Employees
  • ACTU N/A
  • RMMZ N/A
  • Industry
  • ACTU
  • RMMZ Investment Managers
  • Sector
  • ACTU
  • RMMZ Finance
  • Exchange
  • ACTU NYSE
  • RMMZ Nasdaq
  • Market Cap
  • ACTU 135.0M
  • RMMZ 133.6M
  • IPO Year
  • ACTU 2024
  • RMMZ N/A
  • Fundamental
  • Price
  • ACTU $10.35
  • RMMZ $14.45
  • Analyst Decision
  • ACTU Strong Buy
  • RMMZ
  • Analyst Count
  • ACTU 1
  • RMMZ 0
  • Target Price
  • ACTU $20.00
  • RMMZ N/A
  • AVG Volume (30 Days)
  • ACTU 71.1K
  • RMMZ 25.6K
  • Earning Date
  • ACTU 05-21-2025
  • RMMZ 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • RMMZ 7.33%
  • EPS Growth
  • ACTU N/A
  • RMMZ N/A
  • EPS
  • ACTU N/A
  • RMMZ 0.82
  • Revenue
  • ACTU N/A
  • RMMZ N/A
  • Revenue This Year
  • ACTU N/A
  • RMMZ N/A
  • Revenue Next Year
  • ACTU N/A
  • RMMZ N/A
  • P/E Ratio
  • ACTU N/A
  • RMMZ $19.41
  • Revenue Growth
  • ACTU N/A
  • RMMZ N/A
  • 52 Week Low
  • ACTU $5.51
  • RMMZ $12.92
  • 52 Week High
  • ACTU $11.73
  • RMMZ $16.99
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • RMMZ 49.80
  • Support Level
  • ACTU N/A
  • RMMZ $14.37
  • Resistance Level
  • ACTU N/A
  • RMMZ $14.57
  • Average True Range (ATR)
  • ACTU 0.00
  • RMMZ 0.14
  • MACD
  • ACTU 0.00
  • RMMZ 0.08
  • Stochastic Oscillator
  • ACTU 0.00
  • RMMZ 83.33

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.

RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: